# Amatera Bioscience

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/amatera-bioscience

- Industry: Agribusiness
- Headquarters: Boulogne Billancourt, France
- Website: www.amatera.bio
- Total disclosed funding: $7.1M
- Latest round: Seed (Mar 4, 2026)
- Investors on record: 5

## About

Based in Paris, France, and founded in 2022, Amatera Bioscience provides technology solutions for coffee plants. As of 2023, the company is headed by its CEO Omar Dekkiche.  In March 2026, Amatera Bioscience raised EUR 6 million in seed funding co-led by Demea Invest and Oyster Bay, with participation from PINC, Mudcake, and Exceptional Ventures.

The company by leveraging non-GMO technology creates coffee varieties. The firm product range includes naturally caffeine-free coffee which eliminates the chemical and polluting decaffeination processes. Additionally, it also offers robustica which is a climate-resistant product with arabica cup quality. In order to create fresh and enhanced perennial crop types, it also collaborates with agrifood businesses and research facilities. The company will use the March 2026 funding to scale its breeding platform and move beyond coffee and wine grapes.

## Funding rounds

- Seed, Mar 4, 2026, $7.1M — Demea Invest, Oyster Bay, Mudcake, PINC, Exceptional Ventures

## Investors

- Demea Invest (https://capitalatlas.ai/funds/demea-invest) — Seed
- Oyster Bay (https://capitalatlas.ai/funds/oyster-bay) — Seed
- Mudcake (https://capitalatlas.ai/funds/mudcake) — Seed
- PINC (https://capitalatlas.ai/funds/pinc) — Seed
- Exceptional Ventures (https://capitalatlas.ai/funds/exceptional-ventures) — Seed